Tecsys Inc (TCYSF) 7.7176 $TCYSF TECSYS Reports

New Post Public Reply Private Reply Replies (0) Message Board

Jun 16, 2016 at 4:12 PM

Tecsys Inc (TCYSF) 7.7176 $TCYSF

TECSYS Reports Preliminary Financial Results for Q4 and Fiscal Year 2016
Marketwire Canada - Mon May 16, 4:23PM CDT
MONTREAL, QUEBEC--(Marketwired - May 16, 2016) - TECSYS Inc. (TSX:TCS), an industry-leading supply chain management software company, today reports preliminary financial results for the fourth quarter and fiscal year 2016 ending April 30, 2016. All dollar amounts are expressed in Canadian currency.
TCS.TO: 9.85 (-0.07)

Healthcare Supply Chain Management Market Forecast to 2019 - Growing Trend Amongst Hospitals to Adopt Efficient Inventory Management Practices
M2 - Mon Feb 01, 5:16AM CST
Research and Markets (http://www.researchandmarkets.com/research/kn4x5j/healthcare_supply) has announced the addition of the "Healthcare Supply Chain Management Market - Global Forecast to 2019" report to their offering. This report studies the global market over the forecast period of 2014 to 2019. This market is estimated to grow at a CAGR of 8.3% to reach $13,814 million by 2019 from $9,276.5 million in 2014. Key factors that are expected to spur the growth of this market are increasing awareness of the benefits of adopting efficient supply chain management practices, the need to curtail operating cost by the stakeholders in the healthcare arena, prevalence of poor inventory management practices amongst hospitals leading to poor quality of patient care, and compliance with regulatory requirements in various countries. However, the high cost of sophisticated healthcare supply chain management solutions coupled with the lengthy payback period affect the liquidity of mid and small sized organizations thus preventing them for purchasing these solutions are major hindrances to the growth of this market. The North American market dominated the global market in 2014, followed by Europe and Asia. The large share of the North American market can be attributed to the growing trend amongst hospitals to adopt efficient inventory management practices for improving the quality of patient care. Another driving factor is the recent consolidation of hospitals in U.S. which allows the new entity to purchase the solutions as the high cost is now justifiable as it enables them to achieve economies of scale. Companies Profiled: - Cerner Corporation - GHX - Infor - Jump Technologies, Inc. - Logitag Systems Ltd - Mckesson Corporation - Oracle Corporation - Ormed Healthcare Management Systems - SAP AG Group - Tecsys, Inc. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Insights 7 Healthcare Supply Chain Management Market, By Component 8 Healthcare Supply Chain Management Market, By Mode of Delivery 9 Healthcare Supply Chain Management Market, By End User 10 Healthcare Supply Chain Management Market, By Geography 11 Competitive Landscape 12 Company Profiles For more information visit http://www.researchandmarkets.com/research/kn...are_supply
SAP: 76.24 (+0.41), ORCL: 38.66 (+0.22), CERN: 54.40 (-0.11)

TECSYS Reports Second Quarter Fiscal 2016 Financial Results, Records 16% Revenue Growth
Marketwired - Tue Dec 01, 4:10PM CST
TECSYS Inc. (TSX: TCS), an industry-leading supply chain management software company, today announced its results for the second quarter of fiscal year 2016, ended October 31, 2015. All dollar amounts are expressed in Canadian currency and are prepared in accordance with International Financial Reporting Standards (IFRS), and are unaudited.
TCS.TO: 9.85 (-0.07)

Invitation to TECSYS' Conference Call on December 2, 2015
Marketwired - Tue Nov 24, 8:52AM CST
TECSYS Inc. (TSX: TCS) will release its financial results for the second quarter ended October 31, 2015 on December 1, 2015 after the market close. TECSYS' President and CEO, Mr. Peter Brereton, and Mr. Berty Ho-Wo-Cheong, Vice President, Finance and Administration and CFO, will host a conference call on December 2 at 8:30 a.m. EST to present and discuss the results with the analysts.
TCS.TO: 9.85 (-0.07)

StableView Asset Management to Host TECH15 Conference in Toronto
CNW Group - Tue Oct 13, 1:26PM CDT
StableView Asset Management Inc. today announced that it will host the StableView TECH15 Showcase in Toronto, Ontario, on October 14th at the Arcadian Loft, on 401 Bay Street, Simpson Tower, 8(th) floor.
XX.VN: 0.240 (-0.005), OEE.VN: 0.135 (unch), TNC.VN: 2.050 (-0.040), ZAO.VN: 0.115 (-0.025), VPY.VN: 1.030 (+0.010), VGO.VN: 0.170 (-0.005), IOU.VN: 0.400 (unch), AT.VN: 1.320 (-0.030), TCS.TO: 9.85 (-0.07), ESP.TO: 2.21 (-0.08)

TECSYS Announces European Expansion
Marketwired - Tue Sep 22, 6:01AM CDT
TECSYS Inc. (TSX: TCS), an industry-leading supply chain management software company, today announced strategic initiatives destined to bolster the Company's presence in the European supply chain management software market and strengthen its global customer care infrastructure.
TCS.TO: 9.85 (-0.07)

TECSYS Announces Election of Directors and Appointment of Auditors
Marketwired - Thu Sep 17, 3:43PM CDT
TECSYS Inc. (TSX: TCS), (the "Corporation"

announces the results of the matters voted upon at the annual meeting (the "Meeting"

of shareholders of the Corporation (the "Shareholders"

held on September 10, 2015.
TCS.TO: 9.85 (-0.07)

TECSYS Reports Fiscal 2016 First Quarter Financial Results, Records 15% Revenue Growth, 24% Recurring Revenue Growth
Marketwired - Thu Sep 10, 9:50AM CDT
TECSYS Inc. (TSX: TCS), an industry-leading supply chain management software company, today announced its results for the first quarter of fiscal year 2016, ended July 31, 2015.
TCS.TO: 9.85 (-0.07)

Invitation to TECSYS' Conference Call on September 10, 2015
Marketwired - Fri Sep 04, 8:21AM CDT
TECSYS Inc. (TSX: TCS) will release on September 10, 2015 its financial results for the first quarter ended July 31, 2015. TECSYS' President and CEO, Mr. Peter Brereton, and Mr. Berty Ho-Wo-Cheong, Vice President, Finance and Administration and CFO, will host a conference call on September 10 at 4:30 pm EDT to present and discuss the results with the analysts.
TCS.TO: 9.85 (-0.07)

TECSYS Reports Record Revenue & Contract Bookings in Q4 of FY 2015
Marketwired - Wed Jul 08, 2:26PM CDT
TECSYS Inc. (TSX: TCS), an industry-leading supply chain management software company, today announced its results for the fourth quarter and 2015 fiscal year, ended April 30, 2015.
TCS.TO: 9.85 (-0.07)

Invitation to TECSYS' Conference Call on July 8, 2015
Marketwired - Tue Jun 30, 7:21AM CDT
TECSYS Inc. (TSX: TCS) will release on July 8, 2015 its financial results for the fourth quarter and for the fiscal year ended April 30, 2015. TECSYS' President and CEO, Mr. Peter Brereton, and Mr. Berty Ho-Wo-Cheong, Vice President, Finance and Administration and CFO, will host a conference call on July 8 at 4:30 pm EDT to present and discuss the results with the analysts.
TCS.TO: 9.85 (-0.07)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ensign Lawsuit Brews: Investor Stakes High by Dec. 7

Ensign's Alleged Missteps Uncovered Man, grabbing headlines in the finance world often feels like catching a whirlwind, and yet, here we are with Ensign Group's latest debacle. This isn't some run-of-the-mill story we're sifting through. It's a class action lawsuit with teeth, aiming to rope in investors who played ball during a hefty stretch running from February 10,...

Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Axon Body 5: A Leap Forward in AI for Public Safety

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Hims & Hers Faces Securities Lawsuit Amid Stock Dive

Hims & Hers Takes a Hit Right out of the gate, we're seeing Hims & Hers Health, Inc. (NYSE:HIMS) embroiled in a securities class action, thanks to some good old-fashioned alleged corporate shenanigans. It's one of those times where you'd cock an eyebrow and say, "What in the world were they thinking?" The FTC has slapped them with accusations of misleading privacy claims...

Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Master Sommeliers and Italian Producers Clash on Wine Lists

Wines Jockeying for New York’s Coveted Lists Alright, picture a stage set up in New York City like an arena. But instead of gladiators, you've got master sommeliers on one side and Italian wine producers on the other, each armed with their own arguments. They're locked in a battle over what it really takes to get a bottle imbedded on a New York City's prestigious wine...

CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Bio-Thera's New Data: A Game Changer for NSCLC?

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Duolingo Faces Class Action: Deadline Looms for Plaintiffs

Shaking up the education sector like a hot potato, investors have been thrown for a loop with Duolingo’s latest legal debacle. News broke that Kahn Swick & Foti, LLC, with significant backing from their heavyweight partner and former Louisiana Attorney General Charles C. Foti Jr., is spearheading a class action lawsuit against Duolingo, Inc. (NasdaqGS: DUOL). It’s one...

York Space Systems Class Action: Deadline Approaches

Rapid Deadline: October 30 Looms for York Space Systems You blink, and you might miss the deadline. We’re just a step away from deadline day in the York Space Systems’ class action lawsuit. If you've got skin in this game, time's not on your side. Shareholders, particularly those who hopped on the York Space train via their IPO back in January 2026, are staring down...